Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA approves manufacturing change for CEFAZOLIN SODIUM

  • FDA Approval
  • Dec. 04, 2025, 19:12 UTC
  • 39
  • 0 comments

Manufacturing process update for HIKMA FARMACEUTICA. Submission: SUPPL-34. Decision date: 12/01/2025

Comment Full text

SANDOZ

  • FDA Approval
  • Dec. 04, 2025, 09:53 UTC
  • 38
  • 0 comments

FDA approve METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE

Comment Full text

KNACK

  • FDA Approval
  • Dec. 04, 2025, 09:53 UTC
  • 33
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

AMNEAL IRELAND LTD

  • FDA Approval
  • Dec. 03, 2025, 09:44 UTC
  • 41
  • 0 comments

FDA approve ALBUTEROL SULFATE

Comment Full text

ZHEJIANG JIUZHOU BIOPHARMA CO., LTD.

  • FDA Approval
  • Nov. 28, 2025, 14:17 UTC
  • 50
  • 0 comments

FDA approve METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE

Comment Full text

CHANGZHOU PHARMACEUTICAL FACTORY

  • FDA Approval
  • Nov. 28, 2025, 14:17 UTC
  • 37
  • 0 comments

FDA approve RIMEGEPANT SULFATE

Comment Full text

ABBVIE

  • FDA Approval
  • Nov. 28, 2025, 13:43 UTC
  • 33
  • 0 comments

FDA approve PREDNISOLONE ACETATE

Comment Full text

ZYDUS LIFESCIENCES

  • FDA Approval
  • Nov. 26, 2025, 05:11 UTC
  • 47
  • 0 comments

FDA approve VERAPAMIL HYDROCHLORIDE

Comment Full text

MICRO LABS

  • FDA Approval
  • Nov. 26, 2025, 05:11 UTC
  • 54
  • 0 comments

FDA approve AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Comment Full text

OTSUKA PHARM CO LTD

  • FDA Approval
  • Nov. 25, 2025, 21:55 UTC
  • 48
  • 0 comments

FDA approve SIBEPRENLIMAB-SZSI

Comment Full text
  • Previous
  • 53
  • 54
  • 55
  • 56
  • 57
  • Next

Search

News categories

  • Technical Exchange News(11280)
  • Event(2616)
  • SEC News(199049)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(132021)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin